The role of integration of HBV DNA into liver tissues in childhood on the development of hepatocellular carcinoma

儿童时期HBV DNA整合到肝组织中对肝细胞癌发生发展的作用

基本信息

  • 批准号:
    63570434
  • 负责人:
  • 金额:
    $ 0.96万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

Numerous epidemiological studies indicated a striking correspondence between areas where frequency of hepatocellular carcinoma (HCC) is high and where hepatitis B virus (HBV) is endemic. Recently, besides serological evidence, the integration of HBV DNA in HCC has been demonstrated using molecular hybridization technique. However, little is known about the integration in HBV carriers, particularly in childhood. Here, we focused on the presence of HBV DNA in liver tissues of HCC, chronic hepatitis and asymptomatic carriers in childhood.The samples were obtained by biopsy and used for DNA extraction. Purified DNA was digested with Hind III, subjected to agarose gel electrophoresis and analyzed by the Southern blot hybridization technique. The age of patients are between 5-15.In 4 of 5 patients of chronic hepatitis, HBV DNA was integrated in the livers. Diffuse hybridization from 5.0 to 20 kb in size was observed, indicating multiple populations of integrated HBV DNA. All of 2 HCC cases (11 yrs old, male and female), HBV DNA was integrated in tissues. However, blot hybridization showed a sharp band in one, showing monoclonal growth of tumor cells, while diffuse smear from 7.6 to 20.0 kb was detected in the other samples. In 2 asymptomatic carriers, HBV DNA integration was also shown in one.Using molecular cloning method, multiple integration pattern was confirmed in the latter case. In the cases of chronic active hepatitis, rearrangement of host-DNA including integrated proviral DNA were found in several patients. This rearrangement may be important for the accivation of cellular oncogene, such as c-myc.From these results, the integration of HBV DNA was completed in early childhood in most, if not all, HBV carriers. For the early prediction of HBV-related HCC, long term follow-up using molecular biological technique may be necessary in HBV carriers, particularly in chronic hepatitis patients.
大量流行病学研究表明,肝细胞癌(HCC)发病率高的地区与乙型肝炎病毒(HBV)流行的地区之间存在惊人的对应关系。最近,除了血清学证据外,利用分子杂交技术证实了HBV DNA在HCC中的整合。然而,对乙肝病毒携带者的整合知之甚少,特别是在儿童中。在这里,我们关注的是HBV DNA在HCC、慢性肝炎和儿童无症状携带者肝组织中的存在。样本通过活组织检查获得,并用于DNA提取。纯化后的DNA经Hind III酶切,琼脂糖凝胶电泳,并用Southern blot杂交技术进行分析。患者年龄在5-15岁之间。在5例慢性肝炎患者中,有4例HBV DNA在肝脏中整合。观察到大小从5.0到20 kb的弥漫性杂交,表明整合的HBV DNA有多个群体。2例HCC患者(11岁,男,女)均有HBV DNA整合到组织中。然而,印迹杂交在其中一个样品中发现了一个尖锐的条带,显示肿瘤细胞单克隆生长,而在其他样品中检测到7.6 - 20.0 kb的弥漫性涂片。在2例无症状携带者中,1例也出现HBV DNA整合。利用分子克隆方法,证实了后者的多重整合模式。在慢性活动性肝炎病例中,在一些患者中发现了包括整合前病毒DNA在内的宿主DNA重排。这种重排可能对细胞癌基因(如c-myc)的激活很重要。从这些结果来看,HBV DNA的整合在大多数(如果不是全部的话)HBV携带者的幼儿期就完成了。对于HBV携带者,特别是慢性肝炎患者,为了早期预测HBV相关HCC,可能需要使用分子生物学技术进行长期随访。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
森島恒雄: "小児期におけるHBV-DNAのintegrationとその意義" 肝胆膵. 19. 524-530 (1989)
Tsuneo Morishima:“HBV-DNA 整合及其在儿童时期的意义”《肝胆胰》19. 524-530 (1989)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
森島恒雄: "B型肝炎ウイルスの母子感染と発癌" 臨床とウイルス. 16. 314-320 (1988)
Tsuneo Morishima:“乙型肝炎病毒的母婴传播和致癌”《临床和病毒学》16. 314-320 (1988)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Morishima et al.: "Defective immune response against herpes simplex virus among neonates." Progress in Medical Reproductive Immunology 1:47-エ0 1988.
T.Morishima 等人:“新生儿对单纯疱疹病毒的免疫反应缺陷。”医学生殖免疫学进展 1:47-E0 1988。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yaginuma,K.: Journal of Virology.61. 1808-1813 (1987)
Yaginuma,K.:病毒学杂志.61。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Yaginuma: "Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children" Journal of Virology. 61. 1808-1813 (1987)
K.Yaginuma:“乙型肝炎病毒 DNA 在肝细胞癌和儿童慢性活动性肝炎组织中的多重整合位点”病毒学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORISHIMA Tsuneo其他文献

MORISHIMA Tsuneo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORISHIMA Tsuneo', 18)}}的其他基金

Study of the therapeutic agent for the treatment of highly pathogenic influenza
治疗高致病性流感的治疗剂的研究
  • 批准号:
    25670465
  • 财政年份:
    2013
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study on the treatment of highly pathogenic avian influenza H5N1 infections by means of the analysis of pathogenesis of the illness
从发病机制分析高致病性禽流感H5N1感染的治疗研究
  • 批准号:
    23659523
  • 财政年份:
    2011
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study on the pathogenesis of acute encephalitis and encephalopathy for the effective treatment and prevention
急性脑炎及脑病发病机制研究及有效治疗和预防
  • 批准号:
    20249053
  • 财政年份:
    2008
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Research on the pathogenesis, clinical features, diagnostic methods and treatment of acute encephalitis/encephalopathy.
急性脑炎/脑病的发病机制、临床特点、诊断方法和治疗研究。
  • 批准号:
    17209037
  • 财政年份:
    2005
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Pathogenesis on Viral Encephalitis/Encephalopathy
病毒性脑炎/脑病的发病机制
  • 批准号:
    12670745
  • 财政年份:
    2000
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on molecular diagnosis of acute encephalitis
急性脑炎的分子诊断研究
  • 批准号:
    08670874
  • 财政年份:
    1996
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Evaluation of risk and development of a novel therapy for hepatocellular carcinoma in chronic hepatitis B based on microRNA field defect theory
基于microRNA场缺陷理论的慢性乙型肝炎肝细胞癌新疗法评估及开发
  • 批准号:
    20K08367
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation for the liver fibrosis and hepatocellular carcinoma incidence after HCV elimination in patients with chronic hepatitis C
慢性丙型肝炎患者消除HCV后肝纤维化及肝癌发生率评估
  • 批准号:
    20K08820
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of miRNA dysregulation and the risk of hepatocellular carcinoma in chronic hepatitis B after nucleos(t)ide analogue treatment
核(酸)类似物治疗慢性乙型肝炎后miRNA失调与肝细胞癌风险分析
  • 批准号:
    19K17438
  • 财政年份:
    2019
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of molecular basis for improving the treatment efficacy of chronic hepatitis C and preventing the occurrence of hepatocellular carcinoma.
为提高慢性丙型肝炎治疗效果、预防肝细胞癌的发生奠定分子基础。
  • 批准号:
    24390187
  • 财政年份:
    2012
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Micro RNA expressions of chronic hepatitis related hepatocellular carcinoma
慢性肝炎相关性肝细胞癌中微小RNA的表达
  • 批准号:
    24790686
  • 财政年份:
    2012
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Developmental research on dendritic cell-based immunotherapy against chronic hepatitis C and hepatocellular carcinoma
基于树突状细胞的慢性丙型肝炎和肝细胞癌免疫治疗的进展研究
  • 批准号:
    19590765
  • 财政年份:
    2007
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathogenesis of chronic hepatitis C and hepatocellular carcinoma and predictive factors determined by data mining
慢性丙型肝炎和肝细胞癌的发病机制及数据挖掘确定的预测因素
  • 批准号:
    18590724
  • 财政年份:
    2006
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Treatment of chronic hepatitis B for the prevention of development of hepatocellular carcinoma and analyses of hepatitis B virus insertional mutagenesis as a first hit during multistep liver carcinogenesis.
治疗慢性乙型肝炎以预防肝细胞癌的发展,并分析乙型肝炎病毒插入突变作为多步肝癌发生过程中的第一个打击。
  • 批准号:
    16590616
  • 财政年份:
    2004
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proteome analysis in normal liver, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma-For a novel diagnosis, treatment and protection of hepatocellular carcinoma
正常肝脏、慢性肝炎、肝硬化和肝细胞癌的蛋白质组分析-肝细胞癌的新诊断、治疗和保护
  • 批准号:
    15590654
  • 财政年份:
    2003
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional abnormality in the mitochondria and pathogenesis of chronic hepatitis C: relation to hepatocellular carcinoma
线粒体功能异常和慢性丙型肝炎的发病机制:与肝细胞癌的关系
  • 批准号:
    15390226
  • 财政年份:
    2003
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了